GLP-1s are also valuable for improving blood sugar levels, offering a dual benefit for individuals with obesity and type 2 diabetes
Clinical evidence from the STEP trials demonstrated that semaglutide reduces appetite, slows stomach emptying, and helps regulate blood sugar, leading to significant sustained weight loss over 68 weeks of treatment
This synergy not only supports weight loss efforts but also optimizes overall health, which is crucial for both surgical candidates and those pursuing non-surgical cosmetic treatments
vehicle-treated PNA mice (Suppl
A few preliminary studies indicate that combining retatrutide with these or with medicines that operate on FGF21 might enhance liver fat loss and assist in weight management
Whats more, studies on animals have shown GLP-1s can lead to miscarriage or birth defects, which is why most manufacturers recommend stopping taking the drugs during pregnancy, or at least two months before you plan to fall pregnant if at all possible